FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2904272812> ?p ?o ?g. }

• W2904272812 endingPage "259" @default.
• W2904272812 startingPage "252" @default.
• W2904272812 abstract "BACKGROUNDChronic lung allograft dysfunction (CLAD) is the single most important factor limiting long-term survival after lung transplantation (LTx). Azithromycin has been shown to improve CLAD-free and long-term survival, yet the possible impact on early lung allograft function is unclear.METHODSA prospective, randomized, double-blind, placebo-controlled trial of pre-transplant and prompt post-transplant azithromycin treatment was performed at the University Hospitals Leuven. In each arm, 34 patients, transplanted between October 2013 and October 2015, were included for analysis. Study drug was added to standard of care and was administered once before LTx (1,000 mg of azithromycin or placebo) and every other day from Day 1 until Day 31 after LTx (250 mg of azithromycin or placebo). Primary outcome was an anticipated 15% improvement of forced expiratory volume in 1 second (FEV1, percent predicted) during the first 3 months post-LTx. Secondary end-points included length of intubation, days on ventilator, duration of intensive care unit and hospital stay, prevalence and severity of primary graft dysfunction, acute rejection, infection, and CLAD-free and overall survival.RESULTSFEV1 was not significantly different between the 2 groups (p = 0.41). Patients treated with azithromycin demonstrated less airway inflammation, with lower bronchoalveolar lavage (BAL) neutrophilia and BAL interleukin-8 protein levels at Day 30 (p = 0.09 and p = 0.04, respectively) and Day 90 (p = 0.002 and p = 0.08, respectively) after LTx. Other secondary outcomes were not significantly different between placebo and azithromycin groups.CONCLUSIONSPre-transplant and prompt post-transplant azithromycin treatment was not able to improve early lung allograft function. However, the known anti-inflammatory properties of azithromycin were confirmed (NCT01915082). Chronic lung allograft dysfunction (CLAD) is the single most important factor limiting long-term survival after lung transplantation (LTx). Azithromycin has been shown to improve CLAD-free and long-term survival, yet the possible impact on early lung allograft function is unclear. A prospective, randomized, double-blind, placebo-controlled trial of pre-transplant and prompt post-transplant azithromycin treatment was performed at the University Hospitals Leuven. In each arm, 34 patients, transplanted between October 2013 and October 2015, were included for analysis. Study drug was added to standard of care and was administered once before LTx (1,000 mg of azithromycin or placebo) and every other day from Day 1 until Day 31 after LTx (250 mg of azithromycin or placebo). Primary outcome was an anticipated 15% improvement of forced expiratory volume in 1 second (FEV1, percent predicted) during the first 3 months post-LTx. Secondary end-points included length of intubation, days on ventilator, duration of intensive care unit and hospital stay, prevalence and severity of primary graft dysfunction, acute rejection, infection, and CLAD-free and overall survival. FEV1 was not significantly different between the 2 groups (p = 0.41). Patients treated with azithromycin demonstrated less airway inflammation, with lower bronchoalveolar lavage (BAL) neutrophilia and BAL interleukin-8 protein levels at Day 30 (p = 0.09 and p = 0.04, respectively) and Day 90 (p = 0.002 and p = 0.08, respectively) after LTx. Other secondary outcomes were not significantly different between placebo and azithromycin groups. Pre-transplant and prompt post-transplant azithromycin treatment was not able to improve early lung allograft function. However, the known anti-inflammatory properties of azithromycin were confirmed (NCT01915082)." @default.
• W2904272812 created "2018-12-22" @default.
• W2904272812 creator A5009982067 @default.
• W2904272812 creator A5030730695 @default.
• W2904272812 creator A5033247699 @default.
• W2904272812 creator A5033618310 @default.
• W2904272812 creator A5034996987 @default.
• W2904272812 creator A5041130206 @default.
• W2904272812 creator A5055245374 @default.
• W2904272812 creator A5055712465 @default.
• W2904272812 creator A5069256258 @default.
• W2904272812 creator A5070026318 @default.
• W2904272812 creator A5076531628 @default.
• W2904272812 creator A5082171046 @default.
• W2904272812 creator A5082667243 @default.
• W2904272812 creator A5082781557 @default.
• W2904272812 creator A5083035943 @default.
• W2904272812 date "2019-03-01" @default.
• W2904272812 modified "2023-09-24" @default.
• W2904272812 title "Azithromycin and early allograft function after lung transplantation: A randomized, controlled trial" @default.
• W2904272812 cites W1608066808 @default.
• W2904272812 cites W1749324265 @default.
• W2904272812 cites W1869018609 @default.
• W2904272812 cites W1966121050 @default.
• W2904272812 cites W1983076445 @default.
• W2904272812 cites W1988299323 @default.
• W2904272812 cites W2005490939 @default.
• W2904272812 cites W2010596167 @default.
• W2904272812 cites W2034383024 @default.
• W2904272812 cites W2038257815 @default.
• W2904272812 cites W2056406352 @default.
• W2904272812 cites W2068375079 @default.
• W2904272812 cites W2069978011 @default.
• W2904272812 cites W2075732325 @default.
• W2904272812 cites W2106498774 @default.
• W2904272812 cites W2112046799 @default.
• W2904272812 cites W2115027948 @default.
• W2904272812 cites W2115591184 @default.
• W2904272812 cites W2122822166 @default.
• W2904272812 cites W2127410396 @default.
• W2904272812 cites W2136668941 @default.
• W2904272812 cites W2164136965 @default.
• W2904272812 cites W2321158046 @default.
• W2904272812 cites W2333917045 @default.
• W2904272812 cites W2737585766 @default.
• W2904272812 cites W2791163322 @default.
• W2904272812 cites W2791548499 @default.
• W2904272812 cites W2912694583 @default.
• W2904272812 cites W52492176 @default.
• W2904272812 doi "https://doi.org/10.1016/j.healun.2018.12.006" @default.
• W2904272812 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30686699" @default.
• W2904272812 hasPublicationYear "2019" @default.
• W2904272812 type Work @default.
• W2904272812 sameAs 2904272812 @default.
• W2904272812 citedByCount "19" @default.
• W2904272812 countsByYear W29042728122019 @default.
• W2904272812 countsByYear W29042728122020 @default.
• W2904272812 countsByYear W29042728122021 @default.
• W2904272812 countsByYear W29042728122022 @default.
• W2904272812 countsByYear W29042728122023 @default.
• W2904272812 crossrefType "journal-article" @default.
• W2904272812 hasAuthorship W2904272812A5009982067 @default.
• W2904272812 hasAuthorship W2904272812A5030730695 @default.
• W2904272812 hasAuthorship W2904272812A5033247699 @default.
• W2904272812 hasAuthorship W2904272812A5033618310 @default.
• W2904272812 hasAuthorship W2904272812A5034996987 @default.
• W2904272812 hasAuthorship W2904272812A5041130206 @default.
• W2904272812 hasAuthorship W2904272812A5055245374 @default.
• W2904272812 hasAuthorship W2904272812A5055712465 @default.
• W2904272812 hasAuthorship W2904272812A5069256258 @default.
• W2904272812 hasAuthorship W2904272812A5070026318 @default.
• W2904272812 hasAuthorship W2904272812A5076531628 @default.
• W2904272812 hasAuthorship W2904272812A5082171046 @default.
• W2904272812 hasAuthorship W2904272812A5082667243 @default.
• W2904272812 hasAuthorship W2904272812A5082781557 @default.
• W2904272812 hasAuthorship W2904272812A5083035943 @default.
• W2904272812 hasBestOaLocation W29042728121 @default.
• W2904272812 hasConcept C126322002 @default.
• W2904272812 hasConcept C141071460 @default.
• W2904272812 hasConcept C142724271 @default.
• W2904272812 hasConcept C168563851 @default.
• W2904272812 hasConcept C204787440 @default.
• W2904272812 hasConcept C27081682 @default.
• W2904272812 hasConcept C2777714996 @default.
• W2904272812 hasConcept C2777961210 @default.
• W2904272812 hasConcept C2778907293 @default.
• W2904272812 hasConcept C2781448352 @default.
• W2904272812 hasConcept C2911091166 @default.
• W2904272812 hasConcept C501593827 @default.
• W2904272812 hasConcept C71924100 @default.
• W2904272812 hasConcept C86803240 @default.
• W2904272812 hasConcept C89423630 @default.
• W2904272812 hasConceptScore W2904272812C126322002 @default.
• W2904272812 hasConceptScore W2904272812C141071460 @default.
• W2904272812 hasConceptScore W2904272812C142724271 @default.
• W2904272812 hasConceptScore W2904272812C168563851 @default.
• W2904272812 hasConceptScore W2904272812C204787440 @default.
• W2904272812 hasConceptScore W2904272812C27081682 @default.

• next